The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia
2016 · Nature Communications · 245 citations
https://doi.org/10.1038/ncomms12308
T
Thomas M. Ashton
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
1.8K
Citations
9
h-index
9
i10-index
Thomas M. Ashton is an academic researcher from Creighton University. The author has contributed to research in topics: Cancer, Hypoxia, and Metabolism & DNA Repair Mechanisms & Mitochondrial Function and Pathology. The author has an h-index of 9, co-authored 15 publications.
Papers by this author
worksT-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics
2018 · Cell Death and Disease · 84 citations
https://doi.org/10.1038/s41419-018-1131-7
TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy
2017 · British Journal of Cancer · 26 citations
https://doi.org/10.1038/bjc.2017.197
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat